Kiniksa Pharmaceuticals (KNSA) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free KNSA Stock Alerts $20.26 -0.07 (-0.34%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Kiniksa Pharmaceuticals Short Interest DataCurrent Short Volume3,640,000 sharesPrevious Short Volume3,210,000 sharesChange Vs. Previous Month+13.40%Dollar Volume Sold Short$63.48 millionShort Interest Ratio / Days to Cover9.9Last Record DateApril 15, 2024Outstanding Shares70,940,000 sharesPercentage of Shares Shorted5.13%Today's Trading Volume272,503 sharesAverage Trading Volume404,867 sharesToday's Volume Vs. Average67% Short Selling Kiniksa Pharmaceuticals ? Sign up to receive the latest short interest report for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKNSA Short Interest Over TimeKNSA Days to Cover Over TimeKNSA Percentage of Float Shorted Over Time Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> Kiniksa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,640,000 shares $63.48 million +13.4%N/A9.9 $17.44 3/31/20243,210,000 shares $63.33 million +11.9%N/A8.5 $19.73 3/15/20242,870,000 shares $57.37 million +3.2%N/A6.9 $19.99 2/29/20242,780,000 shares $58.77 million +3.0%N/A6.2 $21.14 2/15/20242,700,000 shares $54.46 million -2.2%N/A6.3 $20.17 1/31/20242,760,000 shares $48.66 million +5.8%N/A6.2 $17.63 Get the Latest News and Ratings for KNSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,610,000 shares $49.25 million -9.1%N/A5.4 $18.87 12/31/20232,870,000 shares $50.34 million -12.5%N/A6.1 $17.54 12/15/20233,280,000 shares $59.01 million -4.4%N/A8 $17.99 11/30/20233,430,000 shares $55.46 million +0.6%N/A9.5 $16.17 11/15/20233,410,000 shares $53.64 million +6.2%N/A10.3 $15.73 10/31/20233,210,000 shares $48.95 million -17.7%N/A9.5 $15.25 10/15/20233,900,000 shares $63.61 million +0.8%N/A8.8 $16.31 9/30/20233,870,000 shares $67.22 million +1.3%N/A8.2 $17.37 9/15/20233,820,000 shares $65.47 million -0.8%N/A8 $17.14 8/31/20233,850,000 shares $66.34 million -1.5%N/A7.5 $17.23 8/15/20233,910,000 shares $64.91 million +13.7%N/A7.3 $16.60 7/31/20233,440,000 shares $64.81 million +30.8%N/A6.4 $18.84 7/15/20232,630,000 shares $38.21 million -1.1%N/A5.3 $14.53 6/30/20232,660,000 shares $37.45 million -2.9%N/A6.6 $14.08 6/15/20232,740,000 shares $44.83 million +3.4%N/A6.7 $16.36 5/31/20232,650,000 shares $36.73 million -4.7%N/A6.3 $13.86 5/15/20232,780,000 shares $39.89 million -11.5%N/A6.5 $14.35 4/30/20233,140,000 shares $33.76 million +8.3%N/A7.5 $10.75 4/15/20232,900,000 shares $32.92 million -3.7%N/A7.6 $11.35 3/31/20233,010,000 shares $32.39 million +19.4%N/A7.7 $10.76 3/15/20232,520,000 shares $28.78 million -7.4%N/A6.7 $11.42 2/28/20232,720,000 shares $34.98 million -0.4%N/A7.6 $12.86 2/15/20232,730,000 shares $36.80 million -0.7%N/A7.9 $13.48 1/31/20232,750,000 shares $39.77 million -4.8%N/A7.5 $14.46 1/15/20232,890,000 shares $42.05 million +2.5%N/A7.7 $14.55 12/30/20222,820,000 shares $42.24 million +38.2%N/A7.3 $14.98 12/15/20222,040,000 shares $32.19 million -22.7%N/A5.3 $15.78 11/30/20222,640,000 shares $44.43 million -5.4%N/A7.5 $16.83 11/15/20222,790,000 shares $43.97 million +2.2%N/A8.1 $15.76 10/31/20222,730,000 shares $31.18 million +3.0%N/A8.2 $11.42 10/15/20222,650,000 shares $35.96 million -8.0%N/A7.8 $13.57 9/30/20222,880,000 shares $36.98 million +18.5%N/A8.2 $12.84 9/15/20222,430,000 shares $25.44 million +7.5%N/A7.8 $10.47 8/31/20222,260,000 shares $26.49 million +15.3%N/A6.9 $11.72BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad)BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> KNSA Short Interest - Frequently Asked Questions What is Kiniksa Pharmaceuticals' current short interest? Short interest is the volume of Kiniksa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,640,000 shares of KNSA short. Learn More on Kiniksa Pharmaceuticals' current short interest. What is a good short interest ratio for Kiniksa Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KNSA shares currently have a short interest ratio of 10.0. Learn More on Kiniksa Pharmaceuticals's short interest ratio. Is Kiniksa Pharmaceuticals' short interest increasing or decreasing? Kiniksa Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,640,000 shares, an increase of 13.4% from the previous total of 3,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kiniksa Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Kiniksa Pharmaceuticals: Arcus Biosciences, Inc. (14.45%), ANI Pharmaceuticals, Inc. (1.01%), Day One Biopharmaceuticals, Inc. (15.17%), Xencor, Inc. (10.09%), Morphic Holding, Inc. (12.48%), Protagonist Therapeutics, Inc. (6.00%), Akero Therapeutics, Inc. (11.83%), Dynavax Technologies Co. (14.17%), Ligand Pharmaceuticals Incorporated (4.98%), Taro Pharmaceutical Industries Ltd. (0.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Kiniksa Pharmaceuticals stock? Short selling KNSA is an investing strategy that aims to generate trading profit from Kiniksa Pharmaceuticals as its price is falling. KNSA shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kiniksa Pharmaceuticals? A short squeeze for Kiniksa Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KNSA, which in turn drives the price of the stock up even further. How often is Kiniksa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KNSA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RCUS Short Interest Data ANIP Short Interest Data DAWN Short Interest Data XNCR Short Interest Data MORF Short Interest Data PTGX Short Interest Data AKRO Short Interest Data DVAX Short Interest Data LGND Short Interest Data TARO Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KNSA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold